Tibaldi Giuseppe, Salvador-Carulla Luis, García-Gutierrez Juan Carlos
Centro Studi e Ricerche in Psichiatria – ASLTO2 Torino, Italy.
Curr Clin Pharmacol. 2011 May;6(2):91-9. doi: 10.2174/157488411796151101.
Treatment adherence is related to "self-regulation" of prescribed drugs. Patients organise their drug intake around their own priorities, which may be very different from prescribers' priorities, since most of the patients value their personal concerns and/or their social roles more than the benefits of a prescribed treatment. A gap exists between patients' and professionals' views. This gap is mainly related to patients' health beliefs and physicians' attitudes. A number of strategies can help professionals overcome gaps between their treatment options for depression and schizophrenia and the "real world" alternatives shared by the lay public, patients, their relatives, and political stakeholders. These strategies include integrated care and recovery, family engagement, and the development of a mutualistic patient/physician relationship with the adoption of advance directives and appropriate guidelines that incorporate the patient's choices. The effective implementation of these combined strategies within the person-centred care model empowers patients to collaborate with mental health professionals and their families in making complex health care choices. Barriers to this process include factors affecting the control, contact and communication facets of the patient/physician relationship.
治疗依从性与处方药的“自我管理”有关。患者会根据自身优先级来安排药物服用,这可能与开处方者的优先级大不相同,因为大多数患者更看重个人关切和/或社会角色,而非处方治疗的益处。患者和专业人员的观点之间存在差距。这种差距主要与患者的健康信念和医生的态度有关。一些策略可以帮助专业人员弥合他们针对抑郁症和精神分裂症的治疗方案与普通公众、患者、其亲属和政治利益相关者所采用的“现实世界”替代方案之间的差距。这些策略包括综合护理与康复、家庭参与,以及通过采用预先指示和纳入患者选择的适当指南来建立互利的医患关系。在以患者为中心的护理模式中有效实施这些综合策略,能使患者有能力与心理健康专业人员及其家人合作做出复杂的医疗保健选择。这一过程的障碍包括影响医患关系中控制、接触和沟通方面的因素。